tiprankstipranks
Bionik Laboratories Corp (BNKL)
OTHER OTC:BNKL
US Market
BNKL
Bionik Laboratories
RESEARCH TOOLSreports

Bionik Laboratories (BNKL) Income Statement

9 Followers

Bionik Laboratories Income Statement

Last quarter (Q4 2023), Bionik Laboratories's total revenue was $501.11K, an increase of 162.00% from the same quarter last year. In Q4, Bionik Laboratories's net income was $-1.42M. See Bionik Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 23Mar 22Mar 21Jun 20Mar 19
Total Revenue
$ 1.81M$ 1.27M$ 1.19M$ 2.15M$ 3.25M
Gross Profit
$ 989.88K$ 953.26K$ 923.80K$ 1.26M$ 1.62M
Operating Expenses
$ 5.81M$ 5.73M$ 7.08M$ 12.42M$ 11.10M
Depreciation and Amortization
$ 63.17K$ 102.62K$ 189.73K$ 380.65K$ 348.21K
EBITDA
$ -4.78M$ -9.48M$ -13.03M$ -24.45M$ -6.94M
Operating Income
$ -4.83M$ -4.77M$ -6.16M$ -11.25M$ -7.29M
Other Income/Expenses
$ -120.98K$ -5.64M$ -7.47M$ -13.77M$ -1.07M
Pretax Income
$ -4.95M$ -10.41M$ -13.62M$ -25.02M$ -10.56M
Net Income
$ -4.95M$ -10.41M$ -13.62M$ -24.93M$ -10.56M
Per Share Metrics
Basic EPS
$ -0.72$ -1.78$ -2.66$ -5.60$ -4.47
Diluted EPS
$ -0.72$ -1.78$ -2.66$ -5.60$ -4.47
Weighted Average Shares Outstanding
 6.90M 5.84M 5.13M 4.46M 2.36M
Weighted Average Shares Outstanding (Diluted)
 6.90M 5.84M 5.13M 4.46M 2.36M
Currency in USD

Bionik Laboratories Earnings and Revenue History